A drug exhibits rapid distribution to tissues and slow elimination. What PK parameter primarily drives its long half-life, and how can this be detected?

• A. Clearance; detected by high clearance
• B. Small Vd; detected by short half-life
• C. Large Vd relative to clearance; detected by high Vd and prolonged t1/2
• D. High plasma protein binding; detected by low fu

Answer: (C)

The key idea is that a drug’s half-life depends on the ratio of how widely it distributes (volume of distribution, Vd) to how quickly it is cleared (clearance, CL). The relationship is t1/2 ≈ 0.693 × Vd / CL. If distribution into tissues is very rapid and elimination is slow, the Vd becomes large relative to CL, so the ratio is big and the terminal half-life is long. That means the long half-life arises primarily from a large Vd relative to clearance.

You can detect this by looking at PK data: a high estimated Vd together with a long terminal half-life. In practice, calculating t1/2 from the measured Vd and CL will show a prolonged half-life when Vd is large despite a modest or slow clearance. This pattern indicates extensive tissue distribution is the main factor prolonging the drug’s residence time in the body.